サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1787177

モンテルカスト・ナトリウムの世界市場

Montelukast Sodium

出版日
ページ情報
英文 278 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
モンテルカスト・ナトリウムの世界市場
出版日: 2025年08月08日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 278 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

モンテルカスト・ナトリウムの世界市場は2030年までに11億米ドルに達する見込み

2024年に5億470万米ドルと推定されるモンテルカスト・ナトリウムの世界市場は、2024年から2030年にかけてCAGR 14.1%で成長し、2030年には11億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである錠剤形態は、CAGR12.5%を記録し、分析期間終了時には6億1,550万米ドルに達すると予測されます。経口剤セグメントの成長率は、分析期間でCAGR 16.5％と推定されます。

米国市場は1億3,750万米ドルと推定、中国はCAGR18.6％で成長予測

米国のモンテルカスト・ナトリウム市場は、2024年に1億3,750万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGR18.6%で推移し、2030年までに2億3,580万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ10.6%と12.5%と予測されています。欧州では、ドイツがCAGR 11.2%で成長すると予測されています。

世界のモンテルカスト・ナトリウム市場- 主要動向と促進要因のまとめ

モンテルカスト・ナトリウムが呼吸器疾患治療で広く採用されている理由とは？

モンテルカスト・ナトリウムは、喘息、アレルギー性鼻炎、運動誘発性気管支収縮などの呼吸器疾患の治療薬として広く処方されています。ロイコトリエン受容体拮抗薬（LTRA）であるモンテルカストは、気道収縮の一因となる炎症経路を遮断することにより作用し、喘息管理のための効果的な長期治療薬となっています。公害、気候変動、ライフスタイルの変化による慢性呼吸器疾患の増加に伴い、モンテルカスト・ナトリウムの需要は世界的に急増しています。モンテルカストは、コルチコステロイドとは異なり、経口投与が可能で副作用が少なく、小児にも使用できるため、多くの患者に好まれています。さらに、季節性アレルギーや大気汚染に関連した呼吸器疾患の増加により、処方薬と市販薬の両方でモンテルカストの使用が拡大しています。

モンテルカスト・ナトリウムの市場ポテンシャルを高めている医薬品製剤の進歩とは？

製薬業界では、モンテルカスト・ナトリウムの製剤化とデリバリーにおいて大きな進歩が見られ、バイオアベイラビリティと治療効果が向上しています。咀嚼可能な錠剤や経口顆粒の開発により、小児や老人患者が治療レジメンを守ることが容易になりました。さらに、モンテルカストとレボセチリジンなどの抗ヒスタミン薬との併用療法は、アレルギー症状と呼吸器症状の両方に効果があることから人気を博しています。また、患者のコンプライアンスを向上させ、治療効果を持続させるために、放出制御製剤を含む新しいドラッグデリバリーのメカニズムも研究されています。個別化医療へのシフトは、モンテルカストの反応に影響を与える遺伝的要因の調査をさらに推進し、より的を絞った効果的な治療への道を開いています。製薬企業が革新的な製剤への投資を続ける中、モンテルカスト・ナトリウムのアクセシビリティとユーザビリティの向上が期待されます。

呼吸器疾患の負担増は市場需要をどのように形成しているか？

喘息、慢性閉塞性肺疾患（COPD）、アレルギー性疾患の世界の罹患率の増加により、効果的な呼吸器系治療薬に対する大きな需要が生まれ、モンテルカスト・ナトリウム市場を押し上げています。都市化と工業化は、呼吸器疾患の主な引き金となる大気汚染のレベル上昇につながっています。さらに、呼吸器疾患にかかりやすい老年人口の増加が市場拡大に寄与しています。ヘルスケア・プロバイダーは、より良い喘息管理のために、吸入コルチコステロイドと並行してモンテルカストを補助療法として推奨するようになってきています。COVID-19の大流行も、呼吸器系の健康への関心を高め、慢性呼吸器疾患に対する認識と診断率を高める役割を果たしています。さらに、吸入薬よりも非侵襲的な経口治療に対する患者の嗜好が、いくつかの地域で第一選択薬としてのモンテルカスト・ナトリウムの採用を後押ししています。

モンテルカスト・ナトリウム市場の成長を促進する主な要因は？

モンテルカスト・ナトリウム市場の成長は、呼吸器疾患の有病率の上昇、医薬品イノベーションの拡大、アレルギー疾患に対する意識の高まりなど、いくつかの要因によって牽引されています。費用対効果が高く、入手しやすい喘息治療薬への需要が、先進国市場や新興国市場におけるモンテルカストの採用を後押ししています。また、ジェネリック医薬品メーカーの拡大も市場浸透を高め、モンテルカストをより手頃な価格で広く入手できるようにしました。さらに、モンテルカストと抗ヒスタミン薬やコルチコステロイド薬との併用療法が増加していることも、製薬企業に新たなビジネスチャンスをもたらしています。喘息管理プログラムを推進する政府の取り組みや新興国におけるヘルスケア支出の増加が、市場の成長にさらに寄与しています。個別化医療へのシフトや、より良い治療結果を得るためのバイオマーカー調査も、モンテルカスト・ナトリウムの将来性を高めると予想されます。呼吸器疾患の世界の負担が増加し続けていることから、モンテルカスト・ナトリウム市場は今後数年間で持続的な拡大が見込まれています。

セグメント

剤形（錠剤、内服液）;用途（喘息用途、アレルギー性鼻炎用途、蕁麻疹用途、その他用途）

調査対象企業の例

  • Aarti Pharmalabs Ltd.
  • Apotex Inc.
  • Aurobindo Pharma Limited
  • Cipla Limited
  • Dr. Reddy's Laboratories
  • Hetero Drugs Limited
  • Inke S.A.
  • Intas Pharmaceuticals Ltd.
  • Jai Radhe Sales
  • Kimia Biosciences Ltd.
  • LGM Pharma
  • Merck & Co., Inc.
  • Metrochem API Private Limited
  • Minakem（formerly Delmar Chemicals）
  • Morepen Laboratories Ltd.
  • Neuland Laboratories Ltd.
  • Sanofi S.A.
  • Seqens
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP32214

Global Montelukast Sodium Market to Reach US$1.1 Billion by 2030

The global market for Montelukast Sodium estimated at US$504.7 Million in the year 2024, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 14.1% over the analysis period 2024-2030. Tablets Form, one of the segments analyzed in the report, is expected to record a 12.5% CAGR and reach US$615.5 Million by the end of the analysis period. Growth in the Oral Solutions segment is estimated at 16.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$137.5 Million While China is Forecast to Grow at 18.6% CAGR

The Montelukast Sodium market in the U.S. is estimated at US$137.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$235.8 Million by the year 2030 trailing a CAGR of 18.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.6% and 12.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.2% CAGR.

Global Montelukast Sodium Market - Key Trends & Drivers Summarized

Why Is Montelukast Sodium Gaining Widespread Adoption in Respiratory Disease Treatment?

Montelukast sodium has become a widely prescribed pharmaceutical for managing respiratory conditions such as asthma, allergic rhinitis, and exercise-induced bronchoconstriction. As a leukotriene receptor antagonist (LTRA), montelukast works by blocking inflammatory pathways that contribute to airway constriction, making it an effective long-term therapy for asthma management. With the increasing prevalence of chronic respiratory diseases due to pollution, climate change, and lifestyle factors, the demand for montelukast sodium has surged globally. Unlike corticosteroids, montelukast is preferred by many patients due to its oral administration, fewer side effects, and suitability for pediatric use. Additionally, the rise in seasonal allergies and air pollution-related respiratory issues has expanded the use of montelukast in both prescription and over-the-counter formulations.

What Advancements in Pharmaceutical Formulations Are Enhancing Montelukast Sodium's Market Potential?

The pharmaceutical industry has witnessed significant advancements in the formulation and delivery of montelukast sodium, improving its bioavailability and therapeutic efficacy. The development of chewable tablets and oral granules has made it easier for pediatric and geriatric patients to adhere to treatment regimens. Additionally, combination therapies incorporating montelukast with antihistamines, such as levocetirizine, have gained popularity for their dual-action benefits in managing both allergic and respiratory symptoms. Novel drug delivery mechanisms, including controlled-release formulations, are also being explored to improve patient compliance and prolong therapeutic effects. The shift toward personalized medicine has further driven research into genetic factors influencing montelukast response, paving the way for more targeted and effective treatments. As pharmaceutical companies continue to invest in innovative drug formulations, the accessibility and usability of montelukast sodium are expected to improve.

How Is the Rising Burden of Respiratory Diseases Shaping Market Demand?

The increasing global incidence of asthma, chronic obstructive pulmonary disease (COPD), and allergic conditions has created a substantial demand for effective respiratory therapies, boosting the montelukast sodium market. Urbanization and industrialization have led to rising levels of air pollution, a key trigger for respiratory conditions. Additionally, the growing geriatric population, which is more prone to respiratory diseases, has contributed to market expansion. Healthcare providers are increasingly recommending montelukast as an adjunct therapy alongside inhaled corticosteroids for better asthma management. The COVID-19 pandemic has also played a role in shifting attention toward respiratory health, increasing awareness and diagnosis rates for chronic respiratory conditions. Furthermore, patient preference for non-invasive, oral treatments over inhaled medications has bolstered the adoption of montelukast sodium as a first-line therapy in several regions.

What Are the Key Factors Driving Growth in the Montelukast Sodium Market?

The growth in the montelukast sodium market is driven by several factors, including the rising prevalence of respiratory diseases, expanding pharmaceutical innovations, and increasing awareness about allergic conditions. The demand for cost-effective and easily accessible asthma treatments has propelled the adoption of montelukast across developed and emerging markets. The expansion of generic drug manufacturers has also increased market penetration, making montelukast more affordable and widely available. Additionally, the growing use of combination therapies, where montelukast is paired with antihistamines or corticosteroids, is creating new opportunities for pharmaceutical companies. Government initiatives promoting asthma management programs and increased healthcare spending in emerging economies are further contributing to market growth. The shift toward personalized medicine and research into biomarkers for better treatment outcomes is also expected to enhance the future potential of montelukast sodium. As the global burden of respiratory diseases continues to rise, the montelukast sodium market is set for sustained expansion in the coming years.

SCOPE OF STUDY:

The report analyzes the Montelukast Sodium market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Dosage Form (Tablets Form, Oral Solutions); Application (Asthma Application, Allergic Rhinitis Application, Urticaria Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Aarti Pharmalabs Ltd.
  • Apotex Inc.
  • Aurobindo Pharma Limited
  • Cipla Limited
  • Dr. Reddy's Laboratories
  • Hetero Drugs Limited
  • Inke S.A.
  • Intas Pharmaceuticals Ltd.
  • Jai Radhe Sales
  • Kimia Biosciences Ltd.
  • LGM Pharma
  • Merck & Co., Inc.
  • Metrochem API Private Limited
  • Minakem (formerly Delmar Chemicals)
  • Morepen Laboratories Ltd.
  • Neuland Laboratories Ltd.
  • Sanofi S.A.
  • Seqens
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Montelukast Sodium - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Asthma and Allergic Rhinitis Drives Growing Demand for Montelukast Sodium
    • Rising Awareness of Non-steroidal Treatments for Asthma and Allergies Expands Market Opportunities for Montelukast Sodium
    • Strengthened Focus on Personalized Medicine Drives Adoption of Montelukast Sodium in Tailored Treatment Plans
    • Expanding Pediatric Use of Montelukast Sodium in Asthma Management Strengthens Market Outlook
    • Shift Toward Combination Therapy for Respiratory Disorders Generates Demand for Montelukast Sodium in Multi-drug Formulations
    • Ongoing Clinical Research and Trials Highlight the Benefits of Montelukast Sodium in Treating Multiple Respiratory Conditions
    • Regulatory Approvals for Generic Montelukast Sodium Drive Market Penetration and Reduce Treatment Costs
    • Growth in the Aging Population Accelerates Demand for Montelukast Sodium in Chronic Disease Management
    • Increasing Preference for Oral Medications Drives Montelukast Sodium Adoption in Asthma and Allergy Treatment Protocols
    • Global Initiatives to Improve Respiratory Disease Management Stimulate Demand for Effective Non-corticosteroid Therapies Like Montelukast Sodium
    • Technological Innovations in Drug Delivery Systems Enhance the Efficacy and Market Appeal of Montelukast Sodium
    • Rising Healthcare Expenditure and Investment in Respiratory Disease Treatments Strengthen Market Growth for Montelukast Sodium
    • Growing Use of Montelukast Sodium in Allergy Treatment and Chronic Sinusitis Expands Its Addressable Market Opportunity
    • Increased Focus on Long-term Management of Asthma Drives Sustainable Growth in Montelukast Sodium Usage
    • Expansion of Over-the-counter (OTC) Availability of Montelukast Sodium Formulations Accelerates Market Penetration
    • Increasing Incidence of Air Pollution and Allergies in Urban Populations Drives Growth for Montelukast Sodium
    • Enhanced Patient Compliance with Once-daily Dosing Regimens Strengthens the Adoption of Montelukast Sodium
    • Stronger Focus on Preventive Healthcare Measures Drives Proactive Use of Montelukast Sodium in At-risk Populations
    • Advancements in Combination Therapies that Integrate Montelukast Sodium Expand Treatment Options and Market Potential
    • Ongoing Evaluation of the Safety Profile of Montelukast Sodium Strengthens Its Position as a Frontline Treatment Option
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Montelukast Sodium Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Montelukast Sodium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Montelukast Sodium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Montelukast Sodium by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Tablets Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Tablets Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Tablets Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Oral Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Oral Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Oral Solutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Asthma Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Asthma Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Asthma Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Allergic Rhinitis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Allergic Rhinitis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Allergic Rhinitis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Urticaria Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Urticaria Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Urticaria Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Montelukast Sodium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Montelukast Sodium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Montelukast Sodium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Montelukast Sodium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Montelukast Sodium by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Montelukast Sodium by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Montelukast Sodium by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Montelukast Sodium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Montelukast Sodium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Montelukast Sodium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Montelukast Sodium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Montelukast Sodium by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Montelukast Sodium by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Montelukast Sodium by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Montelukast Sodium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Montelukast Sodium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Montelukast Sodium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Montelukast Sodium by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Montelukast Sodium by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Montelukast Sodium by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Montelukast Sodium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Montelukast Sodium by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Montelukast Sodium by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Montelukast Sodium by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Montelukast Sodium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION